Author: Jane Edwards|| Date Published: December 28, 2016
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
The multiple-award, indefinite-delivery/indefinite-quantity contract covers the development of manufacturing processes and analytical test procedures, regulatory services, manufacturing and product characterization in support of the development of biopharmaceutical drug candidates for infectious diseases, the National Institutes of Health said in a FedBizOpps notice.
The Space Development Agency has awarded $3.5 billion in other transaction authority agreements to Lockheed Martin, L3Harris Technologies, Northrop Grumman…
The Defense Health Agency has awarded TriWest Healthcare Alliance $6.8 billion to continue providing healthcare and administrative services in support…
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
